N. Ikeda, M. Inoue, H. Iso, S. Ikeda, T. Satoh, M. Noda, T. Mizoue, H. Imano, E. Saito, K. Katanoda and 5 other author(s). PLoS medicine, 9 (1):
e1001160(January 2012)6526<m:linebreak></m:linebreak>JID: 101231360; OID: NLM: PMC3265534; 2011/07/28 received; 2011/12/06 accepted; 2012/01/24 epublish; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
G. Liew, P. Mitchell, T. Wong, E. Rochtchina, and J. Wang. JAMA internal medicine, 173 (4):
258-64(February 2013)JID: 101589534; ppublish;<m:linebreak></m:linebreak>
<m:linebreak></m:linebreak>Causalitat; Exemple.
C. Roumie, E. Mitchel, L. Kaltenbach, P. Arbogast, P. Gideon, and M. Griffin. Stroke; a journal of cerebral circulation, 39 (7):
2037-45(July 2008)4450<m:linebreak></m:linebreak>PUBM: Print-Electronic; JID: 0235266; 0 (Anti-Inflammatory Agents, Non-Steroidal); 0 (Cyclooxygenase 2 Inhibitors); 2008/04/24 aheadofprint; ppublish;<m:linebreak></m:linebreak>New-user designs.
D. Moritz, J. Kelsey, and J. Grisso. American journal of epidemiology, 145 (7):
653-60(April 1997)2477<m:linebreak></m:linebreak>Mesures d'associació.
K. Janssen, K. Moons, C. Kalkman, D. Grobbee, and Y. Vergouwe. Journal of clinical epidemiology, 61 (1):
76-86(January 2008)4731<br/>JID: 8801383; 2006/08/22 received; 2007/03/08 revised; 2007/04/20 accepted; 2007/11/26 aheadofprint; ppublish;<br/>Models predictius; Avaluació de riscs.
G. Smith, D. Lawlor, R. Harbord, N. Timpson, I. Day, and S. Ebrahim. PLoS medicine, 4 (12):
e352(December 2007)4891<m:linebreak></m:linebreak>LR: 20081121; JID: 101231360; OID: NLM: PMC2121108; 2006/11/17 received; 2007/10/30 accepted; ppublish;<m:linebreak></m:linebreak>Epidemiologia genètica.
T. Itatsu, A. Nagahara, M. Hojo, A. Miyazaki, T. Murai, M. Nakajima, and S. Watanabe. Internal medicine (Tokyo, Japan), 50 (7):
713-7(January 2011)JID: 9204241; 0 (Serotonin Uptake Inhibitors); 2011/04/01 epublish; ppublish; Confusió absoluta entre cas-control i exposats-no exposats<br/><br/><br/>Tipus d'estudis.
H. Kim. Clinical cancer research : an official journal of the American Association for Cancer Research, 13 (2 Pt 1):
559-65(January 2007)4698<m:linebreak></m:linebreak>LR: 20071203; GR: AI 029530/AI/NIAID NIH HHS/United States; GR: HL 070149/HL/NHLBI NIH HHS/United States; JID: 9502500; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.